Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Books » Medicine » Cardiovascular Disorders » Percutaneous Valve Technology: Present and Future Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
The Life and Times of Cleopatra, Queen of Egypt: A Study in the Origin of the Roman Empire
$207.00
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Rheumatic Mitral Valve Disease: Percutaneous Balloon Mitral Valvuloplasty, Present and Future Perspectives (pp. 523-564)
Tell A Friend
 
Tell someone you know about this product.
Rheumatic Mitral Valve Disease: Percutaneous Balloon Mitral Valvuloplasty, Present and Future Perspectives (pp. 523-564) $100.00
Authors:  (Bernard Iung and Alec Vahanian)
Abstract:
Since it description in 1984, percutaneous mitral commissurotomy (PMC) has been widely used and its indications have been progressively widened. The Inoue technique is now the most widely used, in particular because of its ease of use and its safety, as attested by the low rates of mortality and complications seen in series from experienced centers. The most frequent complication is severe traumatic mitral regurgitation. Immediately after PMC, there is a mean doubling of mitral valve area. Good late functional results are observed in 33 to 72% of patients at 10-12 years, the wide range of rates depending on differences in patient characteristics between series. The most frequent cause of late deterioration is mitral restenosis. Analyses performed in large series have shown that the prediction of immediate and late results of PMC is multifactorial. Besides the severity of the impairment of valve anatomy, age, symptoms, atrial fibrillation and prior commissurotomy have a strong impact on patient outcome.
According to guidelines, percutaneous mitral commissurotomy is now the reference treatment for mitral stenosis with pliable valves in young patients and its efficacy has been validated in randomised trials versus surgery. Mitral stenosis in older patients with more severe impairment of valve anatomy is the most frequent presentation of mitral stenosis in industrialized countries. In this heterogeneous group, PMC should be considered in patients who have otherwise favourable characteristics. PMC can also be considered in selected asymptomatic patients, in particular in order to reduce the thromboembolic risk.
After more than 20 years, PMC is now a mature technique and has virtually replaced surgical commissurotomy in industrialised countries. PMC and valve replacement should be considered as complementary techniques applicable in the different stages and presentations of mitral stenosis. 


Available Options:
Version:
This Item Is Currently Unavailable.
Special Focus Titles
01.Peter Singerís Ethics: A Critical Appraisal
02.Sexism: Past, Present and Future Perspectives
03.Body and Politics: Elite Disability Sport in China
04.Childhood and Adolescence: Tribute to Emanuel Chigier, 1928-2017
05.Renal Replacement Therapy: Controversies and Future Trends
06.Food-Drug Interactions: Pharmacokinetics, Prevention and Potential Side Effects
07.Terrorism and Violence in Islamic History and Theological Responses to the Arguments of Terrorists
08.International Event Management: Bridging the Gap between Theory and Practice
09.The Sino-Indian Border War and the Foreign Policies of China and India (1950-1965)
10.Tsunamis: Detection, Risk Assessment and Crisis Management
11.Sediment Watch: Monitoring, Ecological Risk Assessment and Environmental Management
12.Self-Regulated Learners: Strategies, Performance, and Individual Differences

Nova Science Publishers
© Copyright 2004 - 2018

Rheumatic Mitral Valve Disease: Percutaneous Balloon Mitral Valvuloplasty, Present and Future Perspectives (pp. 523-564)